We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva’s Nasonex Generic Does Not Infringe Merck’s Patent, Judge Says
Teva’s Nasonex Generic Does Not Infringe Merck’s Patent, Judge Says
A federal judge ruled that a generic version of Merck’s Nasonex developed by Teva Pharmaceuticals does not infringe patent claims covering the allergy treatment’s active ingredient.